PDF
ePub
Citation
Print
Abstract
Purpose
The purpose of this study was to investigate the health care utilization in Korean women with cervical cancer and cervical intraepithelial neoplasia (CIN).
Methods
This is a retrospective study. Data were collected using the insurance coverage data-base of Health Insurance Review and Assessment Service (HIRA) from January 1, 2006 to December 31, 2010. Women who were treated for cervical cancer and cervical intraepithelial were included in this study. The data were analyzed using descriptive statistics.
Results
In 2006, women treated for cervical cancer and CIN were 27,109 and 18,794, respectively. The number constantly increased from 2006 to 2010. In particular, the prevalence among women with cervical cancer aged 80 years or over was found to increase. Claims for health care services increased.
Conclusion
Even though new cases of cervical cancer in Korea is decreasing, the number of women being treated and the costs are constantly increasing. Cervical cancer patients are at an increased risk of negative health outcomes. Therefore, screening for cervical cancer should be enforced to promptly treat women with abnormal Pap tests and thus minimize the risks. Every effort should be made to increase awareness about the importance of Human Papilloma Vaccination and regular screening on a personal as well as community and governmental levels.
Figures and Tables
Table 1
Total Number of Women with Cervical Cancer and Cervical Intraepithelial Neoplasia: 2006-2010 (Unit: Person)
Table 2
Proportion of Women with Cervical Cancer and Cervical Intraepithelial Neoplasia by Age Group: 2006-2010 (Unit: Person)
Table 3
Total Medical Expenses for Women with Cervical Cancer and Cervical Intraepithelial Neoplasia: 2006-2010 (Unit: 1,000 won)
References
1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005. 55:74–108.
2. Korea Central Cancer Registry Ministry of Health and Welfare. 2009 Annual report of the Korea Central Cancer Registry. Accessed January 5, 2012. http://www.cancer.go.kr/ncic/cics_f/01/014/index.html.
3. Jeong DH, Lee KB, Kim KT. Management of gynecologic patients with precancerous disease. Korean J Obstet Gynecol. 2010. 53:291–302.
4. Centers for Disease Control and Prevention. Accessed September 17, 2012. http://www.cdc.gov/cancer/cervical/statistics/screening.htm.
5. Jung K, Park S, Kong H, Won Y, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2009. Cancer Res Treat. 2012. 44:11–24.
6. Tae YS. Effects of the self-efficacy promoting program for prevention of uterine cervical cancer on self-efficacy and performance of preventive health behaviors in nurses. J Korean Acad Adult Nurs. 2006. 18:22–30.
7. Statistics Korea. Korean Standard Classification of disease and cause of death. 2010. Daejon: Statistics Korea.
8. Cho IS, Park YS. A study on regular cervical cancer screening behavior among middle-aged women. J Korean Acad Nurs. 2004. 34:141–149.
9. Oh EJ, Lee YE, Lee SO. Cervical cancer screening behavior and related factors among married women. J Korean Soc Matern Child Health. 2010. 14:12–23.
10. Lee EJ, Park JS. Knowledge about cervical cancer, health beliefs and human papillomavirus vaccination rate in female university students. J Korean Oncol Nurs. 2011. 11:65–73.
11. Bang KS, Sung S, Koo B, Kim M, Kim J, Ryu S. Female university student's HPV-related knowledge and influencing factors on HPV vaccination. J Korean Oncol Nurs. 2011. 11:186–192.
12. Park SY, Park CJ, Park JS. The effects of cancer prevention and early detection education on cancer-related knowledge, attitudes, and preventive health behavior of middle-aged women in Korea. J Korean Acad Adult Nurs. 2001. 13:441–450.
13. Jung KI, Park JS. The effect of audiovisual information with videotape on knowledge, attitude and practice of pap smear of cervical cancer. J Korean Soc Matern Child Health. 2004. 8:211–223.
14. Jeong IS, Kim SH, Kim YS. Related factors with the cervical cancer screening and repeated screening. J Korean Soc Matern Child Health. 2004. 8:185–198.
15. Koh K, Lee D, Lee Y, Sohn H. A study on knowledge and attitudes about uterine cervical screening and its utilization among women in a district of Busan city. J Korean Soc Matern Child Health. 2002. 6:93–105.
16. Bosch FX, Castellsagué X, de Sanjose S. HPV vaccines and cervical cancer: screening or vaccination? Br J Cancer. 2008. 98:15–21.
17. Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, et al. Recommendations for cervical cancer prevention in Asia Pacific. Vaccine. 2008. 26:Suppl 12. M89–M98.
18. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O, Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol. 1992. 16:641–649.
19. Shin HR, Franceschi S, Vaccarella S, Roh JW, Ju YH, Oh JK, et al. Prevalence and determinants of genital infection with papillomavirus in female and male university students in Busan, South Korea. J Infect Dis. 2004. 190:468–476.
20. Seo K, Oh J, Shin H. Efficacy of human papillomavirus vaccines as an anticancer vaccine. J Korean Soc Matern Child Health. 2008. 12:1–7.
21. Castellsagué X, Schneider A, Kaufmann AM, Bosch FX. HPV vaccination against cervical cancer in women above 25 years age: key considerations and current perspectives. Gynecol Oncol. 2009. 115:S15–S23.
XML Download